Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 58

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 58
---
3 |
|:-------------------|:--------------|:------------------------|--------:|:----|:--|--------:|
| Audit fees         |               | $                       | 500,607 |     | $ | 500,225 |
| Audit-related fees |               |                         |       — |     |   |       — |
| Tax fees           |               |                         | 150,320 |     |   | 138,650 |
| All other fees     |               |                         |       — |     |   |       — |
| Total Fees         |               | $                       | 650,927 |     | $ | 638,875 |

Audit Fees

Consist of aggregate fees for professional services provided in connection with the annual audit of our financial statements, the review of our quarterly condensed financial statements, consultations on accounting matters directly related to the audit, and comfort letters, consents and assistance with and review of documents filed with the SEC.

<div align='center'>36</div>

Tax Fees

Consist of aggregate fees for tax compliance, tax advice and tax planning services including the review and preparation of our federal and state income tax returns.

#### Recommendation of the Board
<div align='center'>37</div>

### REPORT OF THE AUDIT COMMITTEE
This report is submitted by the Audit Committee of the Board. The Audit Committee consists of the three directors whose names appear below. None of the members of the Audit Committee is an officer or employee of the Company, and the Board has determined that each member of the Audit Committee is "independent" for Audit Committee purposes as that term is defined under Rule 10A-3 of the Exchange Act. Each member of the Audit Committee meets the requirements for financial literacy under the applicable rules and regulations of the SEC. The Board has designated Ms. Reeve as an "audit committee financial expert," as defined under the applicable rules of the SEC. The Audit Committee operates under a written charter adopted by the Board.

The Audit Committee's general role is to assist the Board in monitoring our financial reporting process and related matters. Its specific responsibilities are set forth in its charter.

The Audit Committee has reviewed our consolidated financial statements for 2024 and met with management, as well as with representatives of BDO USA, P.C., the Company's independent registered public accounting firm, to discuss the consolidated financial statements. The Audit Committee also discussed with members of BDO USA, P.C. the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board